BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15472859)

  • 21. Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.
    Taylor SM; Meshnick SR; Worodria W; Andama A; Cattamanchi A; Davis JL; Yoo SD; Byanyima P; Kaswabuli S; Goodman CD; Huang L;
    PLoS One; 2012; 7(11):e49991. PubMed ID: 23166805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of dihydropteroate synthase mutations in Pneumocystis jirovecii from Brazilian AIDS patients.
    Wissmann G; Alvarez-Martinez MJ; Meshnick SR; Dihel AR; Prolla JC
    J Eukaryot Microbiol; 2006; 53(4):305-7. PubMed ID: 16872298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel dihydropteroate synthase gene mutation in Pneumocystis jirovecii among HIV-infected patients in India: Putative association with drug resistance and mortality.
    Singh Y; Mirdha BR; Guleria R; Kabra SK; Mohan A; Chaudhry R; Kumar L; Dwivedi SN; Agarwal SK
    J Glob Antimicrob Resist; 2019 Jun; 17():236-239. PubMed ID: 30658203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and clinical relevance of Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations.
    Matos O; Esteves F
    Parasite; 2010 Sep; 17(3):219-32. PubMed ID: 21073145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients.
    Kazanjian P; Locke AB; Hossler PA; Lane BR; Bartlett MS; Smith JW; Cannon M; Meshnick SR
    AIDS; 1998 May; 12(8):873-8. PubMed ID: 9631140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii strains isolated from Aegean region of Turkey.
    Ozkoc S; Erguden C; Bayram Delibas S
    Parasitol Res; 2018 Oct; 117(10):3103-3108. PubMed ID: 30027382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy.
    Takahashi T; Hosoya N; Endo T; Nakamura T; Sakashita H; Kimura K; Ohnishi K; Nakamura Y; Iwamoto A
    J Clin Microbiol; 2000 Sep; 38(9):3161-4. PubMed ID: 10970350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydropteroate synthase mutations in Pneumocystis pneumonia: impact of applying different definitions of prophylaxis, mortality endpoints and mutant in a single cohort.
    Yoon C; Subramanian A; Chi A; Crothers K; Meshnick SR; Taylor SM; Beard CB; Jarlsberg LG; Lawrence GG; Avery M; Swartzman A; Fong S; Roth B; Huang L;
    Med Mycol; 2013 Aug; 51(6):568-75. PubMed ID: 23470037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
    Huang L; Crothers K; Atzori C; Benfield T; Miller R; Rabodonirina M; Helweg-Larsen J
    Emerg Infect Dis; 2004 Oct; 10(10):1721-8. PubMed ID: 15504256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pneumocystis jiroveci dihydropteroate synthase gene mutations at codon 171 but not at codons 55 or 57 detected in Germany.
    Riebold D; Fritzsche C; Lademann M; Bier A; Reisinger EC
    Clin Infect Dis; 2006 Feb; 42(4):582-3. PubMed ID: 16421813
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular epidemiology of Pneumocystis jiroveci in human immunodeficiency virus-positive and -negative immunocompromised patients in The Netherlands.
    Vanspauwen MJ; Knops VEJ; Bruggeman CA; van Mook WNKA; Linssen CFM
    J Med Microbiol; 2014 Oct; 63(Pt 10):1294-1302. PubMed ID: 25060971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism.
    Helweg-Larsen J; Eugen-Olsen J; Lundgren B
    Scand J Infect Dis; 2000; 32(5):481-3. PubMed ID: 11055650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase (DHPS) mutations.
    Montesinos I; Delforge ML; Ajjaham F; Brancart F; Hites M; Jacobs F; Denis O
    Diagn Microbiol Infect Dis; 2017 Jan; 87(1):32-36. PubMed ID: 27789058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of mutations in dihydropteroate synthase in Pneumocystis jirovecii pneumonia among non-HIV-infected patients.
    Liao TY; Huang YT; Lee TF; Hsueh PR; Yu CJ; Chien JY
    Int J Antimicrob Agents; 2024 Jan; 63(1):107019. PubMed ID: 37925109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Dihydropteroate Synthase (DHPS) Gene Mutations and Mitochondrial Large Subunit (mtLSU) rRNA Genotype Variations in Pneumocystis jirovecii Strains].
    Gülbudak H; Öztürk C; Kuyugöz S; Tezcan Ülger S
    Mikrobiyol Bul; 2021 Jan; 55(1):41-52. PubMed ID: 33590980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients.
    Beser J; Dini L; Botero-Kleiven S; Krabbe M; Lindh J; Hagblom P
    Med Mycol; 2012 Apr; 50(3):320-3. PubMed ID: 21732748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations.
    Hauser PM; Nahimana A; Taffe P; Weber R; Francioli P; Bille J; Rabodonirina M
    Clin Infect Dis; 2010 Aug; 51(4):e28-33. PubMed ID: 20604718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model.
    Iliades P; Meshnick SR; Macreadie IG
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2617-23. PubMed ID: 15215118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumocystis jirovecii dihydropteroate synthase (DHPS) genotypes in non-HIV-immunocompromised patients: a tertiary care reference health centre study.
    Tyagi AK; Mirdha BR; Luthra K; Guleria R; Mohan A; Singh UB; Samantaray JC; Dar L; Iyer VK; Sreenivas V
    Med Mycol; 2011 Feb; 49(2):167-71. PubMed ID: 20718608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydropteroate synthase gene mutation rates in Pneumocystis jirovecii strains obtained from Iranian HIV-positive and non-HIV-positive patients.
    Sheikholeslami MF; Sadraei J; Farnia P; Forozandeh Moghadam M; Emadikochak H
    Med Mycol; 2015 May; 53(4):361-8. PubMed ID: 25631478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.